Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OZANIMOD vs PAMIDRONATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OZANIMOD vs PAMIDRONATE: Safety Overview

Metric OZANIMOD PAMIDRONATE
Total FAERS Reports 7,894 1,639
Deaths Reported 85 184
Death Rate 1.1% 11.2%
Hospitalizations 702 484
Average Patient Age 48.8 yrs 55.1 yrs
% Female Patients 69.9% 61.6%
FDA Approval Date Mar 25, 2020 Apr 30, 2001
Manufacturer Celgene Corporation Hospira, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued